Prescription Justice Statement of Support for Colorado’s Canadian Wholesale Drug Importation Program
Brooklyn, New York – June 17, 2026. Prescription Justice congratulates the State of Colorado on receiving FDA approval for its Canadian wholesale prescription drug importation program.
Colorado has worked for years to develop a program that will allow retail pharmacies to purchase certain prescription drugs at lower wholesale prices available in Canada, with the goal of generating substantial savings for Colorado consumers. Colorado becomes the second state to receive authorization under Section 804 of the Federal Food, Drug, and Cosmetic Act.
Prescription Justice founder and board chair Gabriel Levitt issued the following statement:
"We congratulate Colorado on achieving this important milestone. At a time when Americans pay the highest prescription drug prices in the world, states should be commended for pursuing innovative solutions that can safely lower costs for patients.
Colorado's approval is another step in the right direction. While challenges remain to fully realizing the promise of wholesale importation from Canada, this program will help further demonstrate that importing lower-cost prescription drugs from high-income countries can be done safely and can generate meaningful savings for consumers.
There is still much work to be done to make prescription drug importation work for America. Prescription Justice remains committed to advancing policies that expand access to safe, affordable prescription drugs from abroad and bring American drug prices closer to those paid in other developed countries."
About Prescription Justice
Prescription Justice is a nonprofit organization dedicated to ending the crisis of high drug prices in America. Bringing together doctors, lawyers, public health and consumer advocates, and concerned citizens from across party lines, Prescription Justice advocates for policy, regulatory and legislative reforms centered on drug importation that will expand access to lower-cost medication from abroad and overtime substantially lower the cost of prescription drugs domestically.
